Pyrotinib from MedChemExpress

Product Specs
ItemPyrotinib
CompanyMedChemExpress
Price $228.00Supplier Page View Company Product Page
Catalog NumberHY-104065
Quantity1 mg
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.89%
TypeChemical
Molecular Weight583.08
Molecule NamePyrotinib
FormulaC32H31ClN6O3
Research AreaCancer

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Pyrotinib targeted EGFR/GRP78 mediated cell apoptosis in high EGFR gene copy number gastric cancerJ Exp Clin Cancer ResAugust 19, 2025Lingbo Bao, Xudong Wang, Xiuyong Liao, Dong Li, ChunXue Li, Nan Dai, Xiaoyan Dai, Jing Yang, Nana Hu, Xueling Tong, et al.Beads (M8823) were got from Sigma-Aldrich. Dacomotinib (HY-13272), afatinib (HY-10261), pyrotinib (HY-104065), oxaliplatin (HY-17371), MG132 (HY-13259), SAL003 (HY15869) were purchased from MedChemExpress (New

(2) Protocol for identifying properties of ERBB receptor antagonists using the barcoded ERBBprofiler assaySTAR ProtocolsJune 21, 2024Lukša Popović, Moritz J. Rossner, Michael C. WehrCAS:1421373-65-0 Poziotinib (HM781-36B),Selleckchem,Cat# S7358; CAS: 1092364-38-9 Pyrotinib,MedChemExpress,Cat# HY-104065; CAS: 1269662-73-8 TAS6417 (Zipalertinib),Selleckchem,Cat# S8814; CAS: 1661854-97-2 hEGF,Sigma-Aldrich,Cat#

(3) Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalitiesActa Pharmacologica SinicaJune 1, 2024Ya-ting Zhou, Jia-hui Chu, Shu-han Zhao, Ge-li Li, Zi-yi Fu, Su-jie Zhang, Xue-hu Gao, Wen Ma, Kai Shen, Yuan Gao, et al.(Shanghai, China)",HY-P7109 (in vitro),Pyrotinib,"5, 10, 20, 40, 80 nmol/L","MCE (Shanghai, China)",HY-104065 ,NRG1,50 ng/mL,"Cell Signaling (Danvers, MA, USA)",26941 Chemical,Lapatinib,as directed,"MCE (Shanghai,

(4) Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world studyCell Reports MedicineFebruary 21, 2023Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, Ze-Xin Chen, Jun-Wei Su, Yu-Fa Li, Wen-Feng Li, Qing-Yun Gao, Shi-Ling Zhang, Yu-Qing Chen, et al.HY-12857 Lorlatinib,MCE,Cat# HY-12215 Entrectinib,MCE,Cat# HY-12678 Dabrafenib,MCE,Cat# HY-14660 Pyrotinib,MCE,Cat# HY-104065 Larotrectinib,MCE,Cat# HY-12866 Savolitinib,MCE,Cat# HY-15959 Bozitinib,MCE,Cat# HY-125017 BLU667,MCE,Cat#

(5) Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancerEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical SciencesDecember 15, 2017Li X, Yang C, Wan H, Zhang G, Feng J, Zhang L, Chen X, Zhong D, Lou L, Tao W, et al.

Be the First to Write a Review!

Pyrotinib from MedChemExpress

Description

MedChemExpress

Citations (5)

Reviews

Pyrotinib from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map